ReviewFrontiers in psychiatry2014
The clinical relevance of neurocognitive measures in addiction.
Review in Frontiers in psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- The Effectiveness of Cognitive Bias Modification Interventions for Substance Addictions: A Meta-Analysis.PloS one · 2016Pooled it
- Article
- A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.Addiction (Abingdon, England) · 2019Article
- Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder.Progress in neuro-psychopharmacology & biological psychiatry · 2018Review
- Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2018Review
- Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.Psychopharmacology · 2017Article
- Event-related potentials reflecting smoking cue reactivity and cognitive control as predictors of smoking relapse and resumption.Psychopharmacology · 2016Article
- Predictors of Relapse after Inpatient Opioid Detoxification during 1-Year Follow-Up.Journal of addiction · 2016Article
- Altered performance in a rat gambling task after acute and repeated alcohol exposure.Psychopharmacology · 2015Article
- Addiction specialist's role in liver transplantation procedures for alcoholic liver disease.World journal of hepatology · 2015Review
- Neuroimaging and biomarkers in addiction treatment.Current psychiatry reports · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the major challenges in addiction treatment is relapse prevention, as rates of relapse following treatment remain very high across the main classes of drugs of abuse. Relapse prevention could be improved by a better understanding of the factors that influence treatment outcomes, including better predictors of risk of relapse following treatment. Recent developments in cognitive neuroscience point to neurocognitive measures (i.e., brain-imaging measures during cognitive-task performance) as potential predictors of relapse. These might even be better predictors than self-report measures, such as craving. We first give an overview of the current state of the field, and then discuss the outstanding challenges and future directions in this area of research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.